Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
60
BDWBF Quote, Financials, Valuation and Earnings
Last price:
$0.98
Seasonality move
:
4.71%
Day range:
$0.98 - $0.98
52-week range:
$0.93 - $1.32
Dividend yield:
5.76%
P/E ratio:
26.57x
P/S ratio:
2.24x
P/B ratio:
1.32x
Volume:
78.8K
Avg. volume:
11.3K
1-year change:
4.47%
Market cap:
$12.9B
Revenue:
$5.8B
EPS (TTM):
$0.04
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.5B | $6.9B | $6.2B | $5.8B | |
| Revenue Growth (YoY) | 21.48% | -4.57% | 5.84% | -8.9% | -7.72% | |
| Cost of Revenues | $3.3B | $3.4B | $3.6B | $3.3B | $2.9B | |
| Gross Profit | $3.5B | $3.1B | $3.3B | $3B | $2.9B | |
| Gross Profit Margin | 51.65% | 47.92% | 48.15% | 47.92% | 50.09% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4B | $2.1B | $2.2B | $2.1B | $2B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.2B | $2B | $2B | $2B | $2B | |
| Operating Income | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Net Interest Expenses | $45M | $39M | $50M | $35M | $40M | |
| EBT. Incl. Unusual Items | $1.4B | $1.3B | $1.3B | $1.1B | $913M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $432M | $334M | $447M | $410M | $431M | |
| Net Income to Company | $981M | $949M | $880M | $750M | $520M | |
| Minority Interest in Earnings | $31M | $36M | $28M | $24M | $31M | |
| Net Income to Common Excl Extra Items | $981M | $949M | $880M | $750M | $520M | |
| Basic EPS (Cont. Ops) | $0.07 | $0.07 | $0.06 | $0.06 | $0.04 | |
| Diluted EPS (Cont. Ops) | $0.07 | $0.07 | $0.06 | $0.05 | $0.04 | |
| Weighted Average Basic Share | $13.2B | $13.2B | $13.2B | $13.2B | $13.2B | |
| Weighted Average Diluted Share | $13.2B | $13.2B | $13.3B | $13.3B | $13.3B | |
| EBITDA | $2B | $1.8B | $1.9B | $1.7B | $1.5B | |
| EBIT | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Revenue (Reported) | $6.8B | $6.5B | $6.9B | $6.2B | $5.8B | |
| Operating Income (Reported) | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Operating Income (Adjusted) | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $1.6B | $1.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -17.56% | -26.69% | |
| Cost of Revenues | -- | -- | -- | -- | $716M | |
| Gross Profit | -- | -- | -- | -- | $745M | |
| Gross Profit Margin | -- | -- | -- | -- | 50.99% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | $438M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | $414M | |
| Operating Income | -- | -- | -- | -- | $331M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | $337M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $95M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$8M | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | $234M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | $0.02 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | $0.02 | |
| Weighted Average Basic Share | -- | -- | -- | -- | $13.2B | |
| Weighted Average Diluted Share | -- | -- | -- | -- | $13.3B | |
| EBITDA | -- | -- | -- | -- | $331M | |
| EBIT | -- | -- | -- | -- | $331M | |
| Revenue (Reported) | -- | -- | -- | $1.6B | $1.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | $331M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | $331M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.5B | $6.9B | $6.2B | $5.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.1B | $3.2B | $3.4B | $3.1B | $2.9B | |
| Gross Profit | $3.7B | $3.2B | $3.5B | $3.1B | $2.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.4B | $2.1B | $2.2B | $2.1B | $2B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2.4B | $2.1B | $2.2B | $2.1B | $2B | |
| Operating Income | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Net Interest Expenses | $45M | $39M | $50M | $35M | $40M | |
| EBT. Incl. Unusual Items | $1.4B | $1.3B | $1.3B | $1.1B | $913M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $432M | $334M | $447M | $410M | $431M | |
| Net Income to Company | -- | -- | $880M | $750M | $520M | |
| Minority Interest in Earnings | $31M | $36M | $28M | $24M | $31M | |
| Net Income to Common Excl Extra Items | $981M | $949M | $880M | $750M | $520M | |
| Basic EPS (Cont. Ops) | $0.07 | $0.07 | $0.06 | $0.06 | $0.04 | |
| Diluted EPS (Cont. Ops) | $0.07 | $0.07 | $0.06 | $0.05 | $0.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $2B | $1.8B | $1.9B | $1.7B | $1.5B | |
| EBIT | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Revenue (Reported) | $6.8B | $6.5B | $6.9B | $6.2B | $5.8B | |
| Operating Income (Reported) | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Operating Income (Adjusted) | $1.3B | $1.1B | $1.3B | $1B | $901M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $1.6B | $1.5B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $716M | -- | |
| Gross Profit | -- | -- | -- | $745M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $438M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | $414M | -- | |
| Operating Income | -- | -- | -- | $331M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | $337M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $95M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -$8M | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | $234M | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | $0.02 | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | $0.02 | -- | |
| Weighted Average Basic Share | -- | -- | -- | $13.2B | -- | |
| Weighted Average Diluted Share | -- | -- | -- | $13.3B | -- | |
| EBITDA | -- | -- | -- | $331M | -- | |
| EBIT | -- | -- | -- | $331M | -- | |
| Revenue (Reported) | -- | -- | $1.6B | $1.5B | -- | |
| Operating Income (Reported) | -- | -- | -- | $331M | -- | |
| Operating Income (Adjusted) | -- | -- | -- | $331M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.1B | $2.5B | $3.2B | $2.9B | $2.9B | |
| Short Term Investments | $43M | $67M | $25M | $48M | -- | |
| Accounts Receivable, Net | $412M | $414M | $427M | $360M | $370M | |
| Inventory | $473M | $488M | $444M | $376M | $343M | |
| Prepaid Expenses | $48M | $47M | $72M | $40M | $42M | |
| Other Current Assets | $45M | $14M | $17M | $16M | -- | |
| Total Current Assets | $3.2B | $3.6B | $4.3B | $3.8B | $3.8B | |
| Property Plant And Equipment | $3.6B | $3.2B | $3B | $2.6B | $2.4B | |
| Long-Term Investments | $508M | $510M | $530M | $550M | $572M | |
| Goodwill | $7.1B | $6.6B | $6.4B | $5.9B | -- | |
| Other Intangibles | $2B | $1.8B | $1.8B | $1.7B | -- | |
| Other Long-Term Assets | $10M | $10M | $11M | $13M | -- | |
| Total Assets | $16.6B | $16B | $16.2B | $14.8B | $14.8B | |
| Accounts Payable | $2.1B | $1.9B | $2B | $1.6B | $1.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $32M | $47M | $55M | $42M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.7B | $4.4B | $4.6B | $3.9B | $3.8B | |
| Long-Term Debt | $53M | $77M | $94M | $68M | $60M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $5.2B | $5.4B | $4.5B | $4.4B | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $11B | $10.8B | $10.8B | $10.2B | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $70M | $69M | $65M | $56M | $66M | |
| Total Equity | $11.1B | $10.8B | $10.9B | $10.2B | $10.3B | |
| Total Liabilities and Equity | $16.6B | $16B | $16.2B | $14.8B | $14.8B | |
| Cash and Short Terms | $2.1B | $2.5B | $3.2B | $2.9B | $2.9B | |
| Total Debt | $85M | $124M | $149M | $110M | $60M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.5B | $3.1B | $2.9B | -- | |
| Short Term Investments | $43M | $67M | $25M | $48M | -- | |
| Accounts Receivable, Net | $412M | $414M | $427M | $360M | -- | |
| Inventory | $473M | $488M | $444M | $376M | -- | |
| Prepaid Expenses | $48M | $47M | $72M | $40M | -- | |
| Other Current Assets | $45M | $14M | $17M | $16M | -- | |
| Total Current Assets | $3.2B | $3.6B | $4.3B | $3.8B | -- | |
| Property Plant And Equipment | $3.6B | $3.2B | $3B | $2.6B | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $7.1B | $6.6B | $6.4B | $5.9B | -- | |
| Other Intangibles | $2B | $1.8B | $1.8B | $1.7B | -- | |
| Other Long-Term Assets | $10M | $10M | $11M | $13M | -- | |
| Total Assets | $16.6B | $16B | $16.2B | $14.8B | -- | |
| Accounts Payable | $2.1B | $1.9B | $2B | $1.6B | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $32M | $47M | $55M | $42M | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $4.7B | $4.4B | $4.6B | $3.9B | -- | |
| Long-Term Debt | -- | -- | -- | $68M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.5B | $5.2B | $5.4B | $4.5B | -- | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $70M | $69M | $65M | $56M | -- | |
| Total Equity | $11.1B | $10.8B | $10.9B | $10.2B | -- | |
| Total Liabilities and Equity | $16.6B | $16B | $16.2B | $14.8B | -- | |
| Cash and Short Terms | $2.1B | $2.5B | $3.2B | $2.9B | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $981M | $949M | $880M | $750M | $520M | |
| Depreciation & Amoritzation | $705M | $665M | $654M | $647M | $606M | |
| Stock-Based Compensation | $45M | $52M | $61M | $70M | $58M | |
| Change in Accounts Receivable | -$55M | -$44M | -$76M | $76M | -$29M | |
| Change in Inventories | -$53M | -$75M | $23M | $25M | $26M | |
| Cash From Operations | $1.9B | $1.6B | $1.8B | $1.1B | $951M | |
| Capital Expenditures | $606M | $494M | $498M | $379M | $307M | |
| Cash Acquisitions | $123M | $8M | $8M | $24M | $8M | |
| Cash From Investing | -$731M | -$440M | -$447M | -$409M | -$324M | |
| Dividends Paid (Ex Special Dividend) | $374M | $399M | $500M | $698M | $748M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $19M | $84M | $47M | -- | |
| Long-Term Debt Repaid | -$31M | -$27M | -- | -$131M | -- | |
| Repurchase of Common Stock | -- | $15M | $85M | -- | -- | |
| Other Financing Activities | -- | -- | -$7M | -$8M | -- | |
| Cash From Financing | -$464M | -$500M | -$621M | -$903M | -$738M | |
| Beginning Cash (CF) | $2.1B | $2.5B | $3.2B | $2.9B | $2.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $743M | $451M | $683M | -$274M | -$39M | |
| Ending Cash (CF) | $2.8B | $2.8B | $3.8B | $2.5B | $2.9B | |
| Levered Free Cash Flow | $1.3B | $1.1B | $1.3B | $755M | $644M | |
| Period Ending | 2015-06-30 | 2016-06-30 | 2017-06-30 | 2018-06-30 | 2019-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$351M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -$204M | |
| Stock-Based Compensation | -- | -- | -- | -- | -$3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | $244M | |
| Change in Inventories | -- | -- | -- | -- | -$38M | |
| Cash From Operations | -- | -- | -- | -- | $729M | |
| Capital Expenditures | -- | -- | -- | -- | $157M | |
| Cash Acquisitions | -- | -- | -- | -- | -$144M | |
| Cash From Investing | -- | -- | -- | -- | -$281M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$905M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $254M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | $24M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$349M | |
| Cash From Financing | -- | -- | -- | -- | -$983M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -$8M | |
| Additions / Reductions | -- | -- | -- | -- | -$535M | |
| Ending Cash (CF) | -- | -- | -- | -- | $991M | |
| Levered Free Cash Flow | -- | -- | -- | -- | $572M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $880M | $750M | $520M | |
| Depreciation & Amoritzation | -- | -- | $654M | $647M | $606M | |
| Stock-Based Compensation | -- | -- | $61M | $70M | $58M | |
| Change in Accounts Receivable | -- | -- | -$76M | $76M | -$29M | |
| Change in Inventories | -- | -- | $23M | $25M | $26M | |
| Cash From Operations | $1.9B | $1.6B | $1.8B | $1.1B | $951M | |
| Capital Expenditures | $606.8M | $494.3M | $497.4M | $379M | $307M | |
| Cash Acquisitions | $123.3M | $8M | $8M | $24M | $8M | |
| Cash From Investing | -$732.1M | -$440.3M | -$446.4M | -$409M | -$324M | |
| Dividends Paid (Ex Special Dividend) | $375.1M | $399.5M | $498.8M | $698M | $748M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $19M | $84M | $47M | -- | |
| Long-Term Debt Repaid | -$31M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $15M | $85M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$465.1M | -$500.5M | -$619.8M | -$903M | -$738M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $743.4M | $450.8M | $683.1M | -$274M | -$39M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.3B | $1.1B | $1.3B | $755M | $644M | |
| Period Ending | 2022-02-23 | 2023-02-23 | 2024-02-23 | 2025-02-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Related Companies
Get BDWBF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BDWBF
Sector
P/E ratio
26.57x
17.59x
PEG ratio
--
0.12x
P/B ratio
1.32x
1.53x
Price / LTM sales
2.24x
0.52x
Growth Metrics
BDWBF
Sector
Revenue growth
-26.69%
2.87%
Earnings growth
-45%
2.02%
Revenue (5-year growth)
0.62%
3.51%
Earnings forecast
--
$0.25
Profitability
BDWBF
Sector
Profitability FY 2025
$2.9B
$237.8M
Return on invested capital
5.63%
4.33%
Return on assets
3.98%
3.08%
Return on equity
5.75%
7.97%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
May
7
Estimated Next Earnings Date
May
14
Balance Sheet
BDWBF
Sector
Total cash
$2.5B
$85.8M
Short term investments
$48M
$31.1M
Total assets
$14.8B
$1.1B
Long term debt
--
$5.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
